Association of Proliferative Indices With Various Grades of Breast Carcinoma
- PMID: 37583729
- PMCID: PMC10423845
- DOI: 10.7759/cureus.41865
Association of Proliferative Indices With Various Grades of Breast Carcinoma
Abstract
Aims and objectives: Various grades of breast carcinoma and proliferative indices used as nuclear protein Ki-67 and argyrophilic nucleolar organizer regions (AgNOR) are being compared to each other.
Materials and method: In this observational cross-sectional investigation, 42 breast biopsies from questionable breast areas were collected and preserved in formalin and paraffin before the tissue blocks were made. A thorough medical history regarding the breast tumor and thorough physical examination results were recorded. Two sections were produced, one stained with an immunohistochemical marker called Ki-67 and the other with a unique stain called AgNOR.
Results: Grade I in Nottingham was found to be highest in subjects with Ki-67 1%, grade II in subjects with Ki-67 1-10%, and grade III in subjects with Ki-67>10%. Therefore, a higher Ki-67 score and a higher Nottingham grade were more closely associated. The mean AgNOR score was determined to be highest in Nottingham grade III and lowest in Nottingham grade I. In contrast to grade I and grade II of carcinoma (CA) breast, where there was no statistically significant association between Ki-67 and AgNOR, grade III of CA breast showed a statistically significant link between Ki-67 and AgNOR.
Conclusion: Proliferation has been identified as a distinctive feature of cancer and as a key factor in the prognosis of the disease.
Keywords: agnor; carcinoma; indices; ki-67; proliferative.
Copyright © 2023, Awasthi et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Breast cancer special types: why bother? Reis-Filho JS, Lakhani SR. J Pathol. 2008;216:394–398. - PubMed
-
- Modelling breast cancer: one size does not fit all. Vargo-Gogola T, Rosen JM. Nat Rev Cancer. 2007;7:659–672. - PubMed
-
- Lester SC. Robbins & Cotran pathologic basis of disease. Vol. 10. USA: Elsevier; 2020. The breast; pp. 1051–1066.
-
- Breast cancer classification according to immunohistochemical markers: clinicopathologic features and short-term survival analysis in a population-based study from the South of Switzerland. Spitale A, Mazzola P, Soldini D, Mazzucchelli L, Bordoni A. Ann Oncol. 2009;20:628–635. - PubMed
LinkOut - more resources
Full Text Sources